I do think the chance of bypassing Vpriv EU exclusivity is there, not guranteed but there is a chance. I know CHMP monthly review schedule, don't know COMP review schedule.
I think PRX102 for Fabry IND this qtr is more important at this point.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.